Responses
Respiratory medicine
Original research
Minimum clinically important difference in Quantitative Lung Fibrosis score associated with all-cause mortality in idiopathic pulmonary fibrosis: subanalysis from two phase II trials of pamrevlumab
Compose a Response to This Article
Other responses
No responses have been published for this article.